annual CFF:
$15.97M-$119.36M(-88.20%)Summary
- As of today (September 17, 2025), AVDL annual cash flow from financing activities is $15.97 million, with the most recent change of -$119.36 million (-88.20%) on December 31, 2024.
- During the last 3 years, AVDL annual CFF has risen by +$15.71 million (+5972.24%).
- AVDL annual CFF is now -91.11% below its all-time high of $179.68 million, reached on December 31, 2020.
Performance
AVDL Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.05M+$356.50K(+51.67%)Summary
- As of today (September 17, 2025), AVDL quarterly cash flow from financing activities is $1.05 million, with the most recent change of +$356.50 thousand (+51.67%) on June 1, 2025.
- Over the past year, AVDL quarterly CFF has increased by +$379.10 thousand (+56.80%).
- AVDL quarterly CFF is now -99.15% below its all-time high of $122.92 million, reached on March 31, 2018.
Performance
AVDL quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$3.63M+$379.10K(+11.67%)Summary
- As of today (September 17, 2025), AVDL TTM cash flow from financing activities is $3.63 million, with the most recent change of +$379.10 thousand (+11.67%) on June 1, 2025.
- Over the past year, AVDL TTM CFF has dropped by -$17.91 million (-83.15%).
- AVDL TTM CFF is now -98.07% below its all-time high of $187.91 million, reached on December 31, 2020.
Performance
AVDL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AVDL Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -88.2% | +56.8% | -83.2% |
| 3 y3 years | +5972.2% | +2128.1% | +75.9% |
| 5 y5 years | +10000.0% | -99.1% | -98.0% |
AVDL Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -88.2% | +5972.2% | -98.9% | +104.6% | -97.8% | +147.2% |
| 5 y | 5-year | -91.1% | >+9999.0% | -99.1% | +104.6% | -98.1% | +147.2% |
| alltime | all time | -91.1% | +167.2% | -99.2% | +104.6% | -98.1% | +114.9% |
AVDL Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.05M(+51.7%) | $3.63M(+11.7%) |
| Mar 2025 | - | $690.00K(+37.8%) | $3.25M(-79.4%) |
| Dec 2024 | $15.97M(-88.2%) | $500.90K(-64.0%) | $15.75M(-305.0%) |
| Sep 2024 | - | $1.39M(+108.3%) | -$7.68M(-135.7%) |
| Jun 2024 | - | $667.40K(-94.9%) | $21.54M(-81.7%) |
| Mar 2024 | - | $13.19M(-157.5%) | $117.70M(-15.3%) |
| Dec 2023 | $135.34M(+830.6%) | -$22.93M(-174.9%) | $138.96M(-17.6%) |
| Sep 2023 | - | $30.61M(-68.4%) | $168.67M(+13.9%) |
| Jun 2023 | - | $96.84M(+181.2%) | $148.10M(+189.2%) |
| Mar 2023 | - | $34.44M(+407.3%) | $51.21M(+172.7%) |
| Dec 2022 | $14.54M(+5429.7%) | $6.79M(-32.3%) | $18.78M(+56.7%) |
| Sep 2022 | - | $10.03M(<-9900.0%) | $11.98M(+481.0%) |
| Jun 2022 | - | -$51.60K(-102.6%) | $2.06M(-2.4%) |
| Mar 2022 | - | $2.01M(<-9900.0%) | $2.11M(+731.1%) |
| Dec 2021 | $263.00K(-99.9%) | -$4400.00(-104.0%) | $254.40K(-79.4%) |
| Sep 2021 | - | $109.70K(>+9900.0%) | $1.23M(-85.6%) |
| Jun 2021 | - | $100.00(-99.9%) | $8.58M(-93.2%) |
| Mar 2021 | - | $149.00K(-84.7%) | $125.85M(-33.0%) |
| Dec 2020 | $179.68M(<-9900.0%) | $973.20K(-86.9%) | $187.91M(+0.5%) |
| Sep 2020 | - | $7.46M(-93.6%) | $186.90M(+4.2%) |
| Jun 2020 | - | $117.27M(+88.5%) | $179.40M(+188.9%) |
| Mar 2020 | - | $62.21M(<-9900.0%) | $62.09M(<-9900.0%) |
| Dec 2019 | -$27.00K(-100.0%) | -$40.50K(-1.0%) | -$26.70K(-97.3%) |
| Sep 2019 | - | -$40.90K(+9.7%) | -$989.70K(-59.0%) |
| Jun 2019 | - | -$37.30K(-140.5%) | -$2.41M(-82.6%) |
| Mar 2019 | - | $92.00K(-109.2%) | -$13.86M(-112.7%) |
| Dec 2018 | $112.66M(-583.1%) | -$1.00M(-31.4%) | $108.97M(+4.8%) |
| Sep 2018 | - | -$1.46M(-87.3%) | $103.99M(+3.3%) |
| Jun 2018 | - | -$11.48M(-109.3%) | $100.67M(+1.7%) |
| Mar 2018 | - | $122.92M(-2155.1%) | $98.98M(-506.7%) |
| Dec 2017 | -$23.32M(+193.2%) | -$5.98M(+25.2%) | -$24.34M(+34.7%) |
| Sep 2017 | - | -$4.78M(-63.7%) | -$18.07M(+30.5%) |
| Jun 2017 | - | -$13.17M(+3145.0%) | -$13.85M(+1078.3%) |
| Mar 2017 | - | -$406.00K(-242.5%) | -$1.18M(-84.8%) |
| Dec 2016 | -$7.95M(-66.5%) | $285.00K(-151.1%) | -$7.75M(-3.5%) |
| Sep 2016 | - | -$557.80K(+12.3%) | -$8.03M(+7.5%) |
| Jun 2016 | - | -$496.90K(-92.9%) | -$7.48M(+7.1%) |
| Mar 2016 | - | -$6.98M(+8734.2%) | -$6.98M(-168.1%) |
| Dec 2015 | -$23.75M(-124.7%) | - | - |
| Mar 2015 | - | -$79.00K(-101.1%) | $10.25M(-88.7%) |
| Dec 2014 | $96.00M | $7.33M(+246.3%) | $90.40M(+3.5%) |
| Sep 2014 | - | $2.12M(+141.5%) | $87.33M(+2.5%) |
| Jun 2014 | - | $876.60K(-98.9%) | $85.20M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $80.07M(+1778.0%) | $84.49M(+350.9%) |
| Dec 2013 | $18.27M(+162.7%) | $4.26M(<-9900.0%) | $18.74M(+29.5%) |
| Sep 2013 | - | -$16.90K(-110.0%) | $14.47M(-0.1%) |
| Jun 2013 | - | $168.20K(-98.8%) | $14.49M(-33.0%) |
| Mar 2013 | - | $14.32M(+96.0%) | $21.63M(+158.1%) |
| Dec 2012 | $6.96M(+13.2%) | - | - |
| Jun 2012 | - | $7.31M(+886.4%) | $8.38M(-1.8%) |
| Mar 2012 | - | $741.00K(-730.6%) | $8.53M(+43.3%) |
| Dec 2011 | $6.14M(-893.9%) | -$117.50K(-126.1%) | $5.95M(-4.2%) |
| Sep 2011 | - | $449.70K(-94.0%) | $6.21M(+7.8%) |
| Jun 2011 | - | $7.46M(-505.8%) | $5.76M(-439.3%) |
| Mar 2011 | - | -$1.84M(-1410.0%) | -$1.70M(-1310.0%) |
| Dec 2010 | -$774.00K(-51.1%) | $140.30K(+2598.1%) | $140.30K(-95.6%) |
| Dec 2009 | -$1.58M(-117.8%) | - | - |
| Dec 2008 | $8.88M(+193.8%) | - | - |
| Dec 2007 | $3.02M(-44.8%) | $5200.00(-112.4%) | $3.20M(+0.2%) |
| Sep 2007 | - | -$41.90K(-101.3%) | $3.19M(-1.3%) |
| Jun 2007 | - | $3.21M(>+9900.0%) | $3.23M(+328.2%) |
| Mar 2007 | - | $26.00K(-96.4%) | $755.30K(-81.9%) |
| Dec 2006 | $5.48M(-74.0%) | - | - |
| Jun 2006 | - | $729.30K(-1970.0%) | $4.16M(-44.7%) |
| Mar 2006 | - | -$39.00K(-100.5%) | $7.53M(-62.6%) |
| Dec 2005 | $21.08M(+314.5%) | $7.67M(-282.7%) | $20.17M(+23.6%) |
| Sep 2005 | - | -$4.20M(-202.5%) | $16.32M(-23.5%) |
| Jun 2005 | - | $4.10M(-67.4%) | $21.32M(+22.5%) |
| Mar 2005 | - | $12.60M(+229.3%) | $17.40M(+242.2%) |
| Dec 2004 | $5.09M(-93.2%) | $3.82M(+378.9%) | $5.09M(-93.2%) |
| Sep 2004 | - | $798.60K(+331.7%) | $74.99M(+1.1%) |
| Jun 2004 | - | $185.00K(-33.5%) | $74.19M(-0.6%) |
| Mar 2004 | - | $278.00K(-99.6%) | $74.63M(+0.3%) |
| Dec 2003 | $74.43M(>+9900.0%) | $73.73M(>+9900.0%) | $74.43M(>+9900.0%) |
| Sep 2003 | - | $0.00(-100.0%) | $703.00K(0.0%) |
| Jun 2003 | - | $628.00K(+737.3%) | $703.00K(+837.3%) |
| Mar 2003 | - | $75.00K(-175.0%) | $75.00K(-175.0%) |
| Dec 2002 | $402.00K(-305.1%) | - | - |
| Dec 2001 | -$196.00K(-101.7%) | - | - |
| Dec 2000 | $11.62M(<-9900.0%) | - | - |
| Dec 1999 | -$40.00K(-100.4%) | - | - |
| Dec 1998 | $9.85M(+1540.8%) | - | - |
| Mar 1998 | - | -$100.00K(<-9900.0%) | -$100.00K(<-9900.0%) |
| Dec 1997 | $600.00K(-97.8%) | - | - |
| Dec 1996 | $27.90M | - | - |
| Mar 1996 | - | $0.00 | $0.00 |
FAQ
- What is Avadel Pharmaceuticals plc annual cash flow from financing activities?
- What is the all time high annual CFF for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual CFF year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly CFF year-on-year change?
- What is Avadel Pharmaceuticals plc TTM cash flow from financing activities?
- What is the all time high TTM CFF for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc TTM CFF year-on-year change?
What is Avadel Pharmaceuticals plc annual cash flow from financing activities?
The current annual CFF of AVDL is $15.97M
What is the all time high annual CFF for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual cash flow from financing activities is $179.68M
What is Avadel Pharmaceuticals plc annual CFF year-on-year change?
Over the past year, AVDL annual cash flow from financing activities has changed by -$119.36M (-88.20%)
What is Avadel Pharmaceuticals plc quarterly cash flow from financing activities?
The current quarterly CFF of AVDL is $1.05M
What is the all time high quarterly CFF for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly cash flow from financing activities is $122.92M
What is Avadel Pharmaceuticals plc quarterly CFF year-on-year change?
Over the past year, AVDL quarterly cash flow from financing activities has changed by +$379.10K (+56.80%)
What is Avadel Pharmaceuticals plc TTM cash flow from financing activities?
The current TTM CFF of AVDL is $3.63M
What is the all time high TTM CFF for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high TTM cash flow from financing activities is $187.91M
What is Avadel Pharmaceuticals plc TTM CFF year-on-year change?
Over the past year, AVDL TTM cash flow from financing activities has changed by -$17.91M (-83.15%)